Pfizer To Offer Free Sutent In Nepal, Hurting India CL Chances
This article was originally published in PharmAsia News
Executive Summary
Pfizer plans to make its kidney cancer drug Sutent (sunitinib malate) available for free in Nepal. Pfizer, which launched the drug in India in January, said its patient assistance program in Nepal is in conjunction with Axios Healthcare Development, a non-profit corporation. The free Sutent is to be available in a major hospital and the Patan Academy of Health Sciences. The Pfizer move is expected to hurt Indian drug maker Natco Pharma's chances of getting compulsory license approval to export its generic to Nepal. (Click here for more